Cell Impact AB (publ) (STO:CI)
0.0680
-0.0019 (-2.72%)
Jul 24, 2026, 5:29 PM CET
Cell Impact AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3.95 | 10.86 | 20.39 | 99.89 | 164.67 | 28.56 |
Cash & Short-Term Investments | 3.95 | 10.86 | 20.39 | 99.89 | 164.67 | 28.56 |
Cash Growth | -32.23% | -46.75% | -79.59% | -39.34% | 476.56% | -81.20% |
Accounts Receivable | 2.06 | 0.71 | 4.05 | 0.57 | 16.42 | 24.11 |
Other Receivables | 6.87 | 2.02 | 4.64 | 7.5 | 8.81 | 6.58 |
Total Trade Receivables | 8.92 | 2.73 | 8.69 | 8.07 | 25.23 | 30.69 |
Inventory | 49.56 | 50.02 | 43.38 | 63.89 | 46.78 | 21.93 |
Other Current Assets | - | 7.86 | 0.59 | 0.87 | 1.16 | 46.56 |
Total Current Assets | 62.43 | 71.47 | 73.04 | 172.73 | 237.84 | 127.74 |
Net Property, Plant & Equipment | 77.56 | 76.92 | 165.9 | 181.98 | 143.37 | 91.8 |
Other Intangible Assets | 8.12 | 9.07 | 8.54 | 9.99 | 9.46 | 5.46 |
Long-Term Investments | 0.01 | - | - | - | - | - |
Other Long-Term Assets | 85.69 | 91.92 | 188.22 | 209.22 | 163.69 | 111 |
Total Assets | 148.12 | 163.37 | 261.25 | 381.93 | 401.51 | 238.73 |
Accounts Payable | 2.47 | 4.37 | 1.59 | 9.29 | 13.33 | 15.1 |
Accrued Expenses | 7.11 | 9.45 | 8.56 | 24.55 | 15.44 | 55.48 |
Current Portion of Long-Term Debt | 4.46 | 14.82 | 8.21 | 8.21 | 8.21 | 0.71 |
Current Portion of Leases | 4.84 | 4.84 | 4.62 | 4.16 | 3.15 | 2.72 |
Unearned Revenue | - | - | - | - | 0.59 | 3.3 |
Other Current Liabilities | 1.54 | 1.89 | 1.1 | 1.98 | 3.1 | 2.7 |
Total Current Liabilities | 20.42 | 35.37 | 24.08 | 48.19 | 43.83 | 80.03 |
Long-Term Debt | 0.89 | 1.07 | 7.41 | 15.63 | 23.84 | 3.93 |
Long-Term Leases | 4.67 | 5.9 | 10.68 | 14.75 | 9.5 | 12.15 |
Total Long-Term Liabilities | 5.56 | 6.98 | 18.09 | 30.38 | 33.34 | 16.08 |
Total Liabilities | 25.98 | 42.34 | 42.17 | 78.56 | 77.17 | 96.1 |
Common Stock | 60.9 | 58.92 | 80.6 | 68.46 | 8.78 | 8.76 |
Additional Paid-in Capital | 724.18 | 725.34 | 737.79 | 733.77 | 693.04 | 407.12 |
Retained Earnings | -662.94 | -663.22 | -599.3 | -498.87 | -377.47 | -273.25 |
Shareholders' Equity | 122.14 | 121.03 | 219.08 | 303.37 | 324.35 | 142.63 |
Total Liabilities & Equity | 148.12 | 163.37 | 261.25 | 381.93 | 401.51 | 238.73 |
Total Debt | 14.87 | 26.63 | 30.92 | 42.75 | 44.7 | 19.51 |
Net Cash (Debt) | -10.92 | -15.77 | -10.53 | 57.15 | 119.97 | 9.05 |
Net Cash Growth | - | - | - | -52.37% | 1225.78% | -93.04% |
Net Cash Per Share | -0.05 | -0.09 | -0.06 | 5.21 | 15.84 | 1.53 |
Book Value | 122.14 | 121.03 | 219.08 | 303.37 | 324.35 | 142.63 |
Book Value Per Share | 0.56 | 0.72 | 1.30 | 27.67 | 42.83 | 24.09 |
Tangible Book Value | 114.02 | 111.96 | 210.54 | 293.38 | 314.89 | 137.16 |
Tangible Book Value Per Share | 0.52 | 0.66 | 1.25 | 26.76 | 41.58 | 23.17 |